delete National Health (Pharmaceutical Benefits) Amendment Regulations 2000 (No. 1)
Amendment to the National Health (Pharmaceutical Benefits) Regulations 2000, modifying the Pharmaceutical Benefits Scheme (PBS) which provides government subsidies for prescription medicines. This instrument likely adjusts drug listing criteria, pricing controls, eligibility requirements, or administrative procedures, expanding bureaucratic control over pharmaceutical markets.
The PBS represents a massive government intervention that distorts pharmaceutical markets through price controls and subsidies. This amendment expands bureaucratic control, adding compliance costs for pharmacies and doctors while stifling innovation and market efficiency. Unseen costs include: delayed access to new drugs due to listing negotiations, reduced R&D investment from price ceilings, administrative burden on healthcare providers, and taxpayer funding that misallocates resources. Australians would be better off with a free market where prices reflect scarcity, innovation thrives, and individuals make their own healthcare choices without government interference.